Cargando…
The leader peptide of mutacin 1140 has distinct structural components compared to related class I lantibiotics
Lantibiotics are ribosomally synthesized peptide antibiotics composed of an N-terminal leader peptide that promotes the core peptide's interaction with the post translational modification (PTM) enzymes. Following PTMs, mutacin 1140 is transported out of the cell and the leader peptide is cleave...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263518/ https://www.ncbi.nlm.nih.gov/pubmed/25400246 http://dx.doi.org/10.1002/mbo3.222 |
_version_ | 1782348587174199296 |
---|---|
author | Escano, Jerome Stauffer, Byron Brennan, Jacob Bullock, Monica Smith, Leif |
author_facet | Escano, Jerome Stauffer, Byron Brennan, Jacob Bullock, Monica Smith, Leif |
author_sort | Escano, Jerome |
collection | PubMed |
description | Lantibiotics are ribosomally synthesized peptide antibiotics composed of an N-terminal leader peptide that promotes the core peptide's interaction with the post translational modification (PTM) enzymes. Following PTMs, mutacin 1140 is transported out of the cell and the leader peptide is cleaved to yield the antibacterial peptide. Mutacin 1140 leader peptide is structurally unique compared to other class I lantibiotic leader peptides. Herein, we further our understanding of the structural differences of mutacin 1140 leader peptide with regard to other class I leader peptides. We have determined that the length of the leader peptide is important for the biosynthesis of mutacin 1140. We have also determined that mutacin 1140 leader peptide contains a novel four amino acid motif compared to related lantibiotics. PTM enzyme recognition of the leader peptide appears to be evolutionarily distinct from related class I lantibiotics. Our study on mutacin 1140 leader peptide provides a basis for future studies aimed at understanding its interaction with the PTM enzymes. |
format | Online Article Text |
id | pubmed-4263518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BlackWell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-42635182014-12-15 The leader peptide of mutacin 1140 has distinct structural components compared to related class I lantibiotics Escano, Jerome Stauffer, Byron Brennan, Jacob Bullock, Monica Smith, Leif Microbiologyopen Original Research Lantibiotics are ribosomally synthesized peptide antibiotics composed of an N-terminal leader peptide that promotes the core peptide's interaction with the post translational modification (PTM) enzymes. Following PTMs, mutacin 1140 is transported out of the cell and the leader peptide is cleaved to yield the antibacterial peptide. Mutacin 1140 leader peptide is structurally unique compared to other class I lantibiotic leader peptides. Herein, we further our understanding of the structural differences of mutacin 1140 leader peptide with regard to other class I leader peptides. We have determined that the length of the leader peptide is important for the biosynthesis of mutacin 1140. We have also determined that mutacin 1140 leader peptide contains a novel four amino acid motif compared to related lantibiotics. PTM enzyme recognition of the leader peptide appears to be evolutionarily distinct from related class I lantibiotics. Our study on mutacin 1140 leader peptide provides a basis for future studies aimed at understanding its interaction with the PTM enzymes. BlackWell Publishing Ltd 2014-12 2014-11-17 /pmc/articles/PMC4263518/ /pubmed/25400246 http://dx.doi.org/10.1002/mbo3.222 Text en © 2014 The Authors. MicrobiologyOpen published by John Wiley & Sons Ltd. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Escano, Jerome Stauffer, Byron Brennan, Jacob Bullock, Monica Smith, Leif The leader peptide of mutacin 1140 has distinct structural components compared to related class I lantibiotics |
title | The leader peptide of mutacin 1140 has distinct structural components compared to related class I lantibiotics |
title_full | The leader peptide of mutacin 1140 has distinct structural components compared to related class I lantibiotics |
title_fullStr | The leader peptide of mutacin 1140 has distinct structural components compared to related class I lantibiotics |
title_full_unstemmed | The leader peptide of mutacin 1140 has distinct structural components compared to related class I lantibiotics |
title_short | The leader peptide of mutacin 1140 has distinct structural components compared to related class I lantibiotics |
title_sort | leader peptide of mutacin 1140 has distinct structural components compared to related class i lantibiotics |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263518/ https://www.ncbi.nlm.nih.gov/pubmed/25400246 http://dx.doi.org/10.1002/mbo3.222 |
work_keys_str_mv | AT escanojerome theleaderpeptideofmutacin1140hasdistinctstructuralcomponentscomparedtorelatedclassilantibiotics AT staufferbyron theleaderpeptideofmutacin1140hasdistinctstructuralcomponentscomparedtorelatedclassilantibiotics AT brennanjacob theleaderpeptideofmutacin1140hasdistinctstructuralcomponentscomparedtorelatedclassilantibiotics AT bullockmonica theleaderpeptideofmutacin1140hasdistinctstructuralcomponentscomparedtorelatedclassilantibiotics AT smithleif theleaderpeptideofmutacin1140hasdistinctstructuralcomponentscomparedtorelatedclassilantibiotics AT escanojerome leaderpeptideofmutacin1140hasdistinctstructuralcomponentscomparedtorelatedclassilantibiotics AT staufferbyron leaderpeptideofmutacin1140hasdistinctstructuralcomponentscomparedtorelatedclassilantibiotics AT brennanjacob leaderpeptideofmutacin1140hasdistinctstructuralcomponentscomparedtorelatedclassilantibiotics AT bullockmonica leaderpeptideofmutacin1140hasdistinctstructuralcomponentscomparedtorelatedclassilantibiotics AT smithleif leaderpeptideofmutacin1140hasdistinctstructuralcomponentscomparedtorelatedclassilantibiotics |